SILVI, an open-source pipeline for T-cell epitope selection

High-throughput screening of available genomic data and identification of potential antigenic candidates have promoted the development of epitope-based vaccines and therapeutics. Several immunoinformatic tools are available to predict potential epitopes and other immunogenicity-related features, yet...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:PloS one Jg. 17; H. 9; S. e0273494
Hauptverfasser: Pissarra, Joana, Dorkeld, Franck, Loire, Etienne, Bonhomme, Vincent, Sereno, Denis, Lemesre, Jean-Loup, Holzmuller, Philippe
Format: Journal Article
Sprache:Englisch
Veröffentlicht: San Francisco Public Library of Science 07.09.2022
Public Library of Science (PLoS)
Schlagworte:
ISSN:1932-6203, 1932-6203
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Abstract High-throughput screening of available genomic data and identification of potential antigenic candidates have promoted the development of epitope-based vaccines and therapeutics. Several immunoinformatic tools are available to predict potential epitopes and other immunogenicity-related features, yet it is still challenging and time-consuming to compare and integrate results from different algorithms. We developed the R script SILVI (short for: from in silico to in vivo ), to assist in the selection of the potentially most immunogenic T-cell epitopes from Human Leukocyte Antigen (HLA)-binding prediction data. SILVI merges and compares data from available HLA-binding prediction servers, and integrates additional relevant information of predicted epitopes, namely BLASTp alignments with host proteins and physical-chemical properties. The two default criteria applied by SILVI and additional filtering allow the fast selection of the most conserved, promiscuous, strong binding T-cell epitopes. Users may adapt the script at their discretion as it is written in open-source R language. To demonstrate the workflow and present selection options, SILVI was used to integrate HLA-binding prediction results of three example proteins, from viral, bacterial and parasitic microorganisms, containing validated epitopes included in the Immune Epitope Database (IEDB), plus the Human Papillomavirus (HPV) proteome. Applying different filters on predicted IC50, hydrophobicity and mismatches with host proteins allows to significantly reduce the epitope lists with favourable sensitivity and specificity to select immunogenic epitopes. We contemplate SILVI will assist T-cell epitope selections and can be continuously refined in a community-driven manner, helping the improvement and design of peptide-based vaccines or immunotherapies. SILVI development version is available at: github.com/JoanaPissarra/SILVI2020 and https://doi.org/10.5281/zenodo.6865909 .
AbstractList High-throughput screening of available genomic data and identification of potential antigenic candidates have promoted the development of epitope-based vaccines and therapeutics. Several immunoinformatic tools are available to predict potential epitopes and other immunogenicity-related features, yet it is still challenging and time-consuming to compare and integrate results from different algorithms. We developed the R script SILVI (short for: from in silico to in vivo), to assist in the selection of the potentially most immunogenic T-cell epitopes from Human Leukocyte Antigen (HLA)-binding prediction data. SILVI merges and compares data from available HLA-binding prediction servers, and integrates additional relevant information of predicted epitopes, namely BLASTp alignments with host proteins and physical-chemical properties. The two default criteria applied by SILVI and additional filtering allow the fast selection of the most conserved, promiscuous, strong binding T-cell epitopes. Users may adapt the script at their discretion as it is written in open-source R language. To demonstrate the workflow and present selection options, SILVI was used to integrate HLA-binding prediction results of three example proteins, from viral, bacterial and parasitic microorganisms, containing validated epitopes included in the Immune Epitope Database (IEDB), plus the Human Papillomavirus (HPV) proteome. Applying different filters on predicted IC50, hydrophobicity and mismatches with host proteins allows to significantly reduce the epitope lists with favourable sensitivity and specificity to select immunogenic epitopes. We contemplate SILVI will assist T-cell epitope selections and can be continuously refined in a community-driven manner, helping the improvement and design of peptide-based vaccines or immunotherapies. SILVI development version is available at: github.com/JoanaPissarra/SILVI2020 and
High-throughput screening of available genomic data and identification of potential antigenic candidates have promoted the development of epitope-based vaccines and therapeutics. Several immunoinformatic tools are available to predict potential epitopes and other immunogenicity-related features, yet it is still challenging and time-consuming to compare and integrate results from different algorithms. We developed the R script SILVI (short for: from in silico to in vivo), to assist in the selection of the potentially most immunogenic T-cell epitopes from Human Leukocyte Antigen (HLA)-binding prediction data. SILVI merges and compares data from available HLA-binding prediction servers, and integrates additional relevant information of predicted epitopes, namely BLASTp alignments with host proteins and physical-chemical properties. The two default criteria applied by SILVI and additional filtering allow the fast selection of the most conserved, promiscuous, strong binding T-cell epitopes. Users may adapt the script at their discretion as it is written in open-source R language. To demonstrate the workflow and present selection options, SILVI was used to integrate HLA-binding prediction results of three example proteins, from viral, bacterial and parasitic microorganisms, containing validated epitopes included in the Immune Epitope Database (IEDB), plus the Human Papillomavirus (HPV) proteome. Applying different filters on predicted IC50, hydrophobicity and mismatches with host proteins allows to significantly reduce the epitope lists with favourable sensitivity and specificity to select immunogenic epitopes. We contemplate SILVI will assist T-cell epitope selections and can be continuously refined in a community-driven manner, helping the improvement and design of peptide-based vaccines or immunotherapies. SILVI development version is available at: github.com/JoanaPissarra/SILVI2020 and https://doi.org/10.5281/zenodo.6865909.
High-throughput screening of available genomic data and identification of potential antigenic candidates have promoted the development of epitope-based vaccines and therapeutics. Several immunoinformatic tools are available to predict potential epitopes and other immunogenicity-related features, yet it is still challenging and time-consuming to compare and integrate results from different algorithms. We developed the R script SILVI (short for: from in silico to in vivo ), to assist in the selection of the potentially most immunogenic T-cell epitopes from Human Leukocyte Antigen (HLA)-binding prediction data. SILVI merges and compares data from available HLA-binding prediction servers, and integrates additional relevant information of predicted epitopes, namely BLASTp alignments with host proteins and physical-chemical properties. The two default criteria applied by SILVI and additional filtering allow the fast selection of the most conserved, promiscuous, strong binding T-cell epitopes. Users may adapt the script at their discretion as it is written in open-source R language. To demonstrate the workflow and present selection options, SILVI was used to integrate HLA-binding prediction results of three example proteins, from viral, bacterial and parasitic microorganisms, containing validated epitopes included in the Immune Epitope Database (IEDB), plus the Human Papillomavirus (HPV) proteome. Applying different filters on predicted IC50, hydrophobicity and mismatches with host proteins allows to significantly reduce the epitope lists with favourable sensitivity and specificity to select immunogenic epitopes. We contemplate SILVI will assist T-cell epitope selections and can be continuously refined in a community-driven manner, helping the improvement and design of peptide-based vaccines or immunotherapies. SILVI development version is available at: https://github.com/JoanaPissarra/SILVI2020 and https://doi.org/10.5281/zenodo.6865909 .
High-throughput screening of available genomic data and identification of potential antigenic candidates have promoted the development of epitope-based vaccines and therapeutics. Several immunoinformatic tools are available to predict potential epitopes and other immunogenicity-related features, yet it is still challenging and time-consuming to compare and integrate results from different algorithms. We developed the R script SILVI (short for: from in silico to in vivo ), to assist in the selection of the potentially most immunogenic T-cell epitopes from Human Leukocyte Antigen (HLA)-binding prediction data. SILVI merges and compares data from available HLA-binding prediction servers, and integrates additional relevant information of predicted epitopes, namely BLASTp alignments with host proteins and physical-chemical properties. The two default criteria applied by SILVI and additional filtering allow the fast selection of the most conserved, promiscuous, strong binding T-cell epitopes. Users may adapt the script at their discretion as it is written in open-source R language. To demonstrate the workflow and present selection options, SILVI was used to integrate HLA-binding prediction results of three example proteins, from viral, bacterial and parasitic microorganisms, containing validated epitopes included in the Immune Epitope Database (IEDB), plus the Human Papillomavirus (HPV) proteome. Applying different filters on predicted IC50, hydrophobicity and mismatches with host proteins allows to significantly reduce the epitope lists with favourable sensitivity and specificity to select immunogenic epitopes. We contemplate SILVI will assist T-cell epitope selections and can be continuously refined in a community-driven manner, helping the improvement and design of peptide-based vaccines or immunotherapies. SILVI development version is available at: github.com/JoanaPissarra/SILVI2020 and https://doi.org/10.5281/zenodo.6865909 .
High-throughput screening of available genomic data and identification of potential antigenic candidates have promoted the development of epitope-based vaccines and therapeutics. Several immunoinformatic tools are available to predict potential epitopes and other immunogenicity-related features, yet it is still challenging and time-consuming to compare and integrate results from different algorithms. We developed the R script SILVI (short for: from in silico to in vivo), to assist in the selection of the potentially most immunogenic T-cell epitopes from Human Leukocyte Antigen (HLA)-binding prediction data. SILVI merges and compares data from available HLA-binding prediction servers, and integrates additional relevant information of predicted epitopes, namely BLASTp alignments with host proteins and physical-chemical properties. The two default criteria applied by SILVI and additional filtering allow the fast selection of the most conserved, promiscuous, strong binding T-cell epitopes. Users may adapt the script at their discretion as it is written in open-source R language. To demonstrate the workflow and present selection options, SILVI was used to integrate HLA-binding prediction results of three example proteins, from viral, bacterial and parasitic microorganisms, containing validated epitopes included in the Immune Epitope Database (IEDB), plus the Human Papillomavirus (HPV) proteome. Applying different filters on predicted IC50, hydrophobicity and mismatches with host proteins allows to significantly reduce the epitope lists with favourable sensitivity and specificity to select immunogenic epitopes. We contemplate SILVI will assist T-cell epitope selections and can be continuously refined in a community-driven manner, helping the improvement and design of peptide-based vaccines or immunotherapies. SILVI development version is available at: github.com/JoanaPissarra/SILVI2020 and https://doi.org/10.5281/zenodo.6865909.High-throughput screening of available genomic data and identification of potential antigenic candidates have promoted the development of epitope-based vaccines and therapeutics. Several immunoinformatic tools are available to predict potential epitopes and other immunogenicity-related features, yet it is still challenging and time-consuming to compare and integrate results from different algorithms. We developed the R script SILVI (short for: from in silico to in vivo), to assist in the selection of the potentially most immunogenic T-cell epitopes from Human Leukocyte Antigen (HLA)-binding prediction data. SILVI merges and compares data from available HLA-binding prediction servers, and integrates additional relevant information of predicted epitopes, namely BLASTp alignments with host proteins and physical-chemical properties. The two default criteria applied by SILVI and additional filtering allow the fast selection of the most conserved, promiscuous, strong binding T-cell epitopes. Users may adapt the script at their discretion as it is written in open-source R language. To demonstrate the workflow and present selection options, SILVI was used to integrate HLA-binding prediction results of three example proteins, from viral, bacterial and parasitic microorganisms, containing validated epitopes included in the Immune Epitope Database (IEDB), plus the Human Papillomavirus (HPV) proteome. Applying different filters on predicted IC50, hydrophobicity and mismatches with host proteins allows to significantly reduce the epitope lists with favourable sensitivity and specificity to select immunogenic epitopes. We contemplate SILVI will assist T-cell epitope selections and can be continuously refined in a community-driven manner, helping the improvement and design of peptide-based vaccines or immunotherapies. SILVI development version is available at: github.com/JoanaPissarra/SILVI2020 and https://doi.org/10.5281/zenodo.6865909.
Audience Academic
Author Dorkeld, Franck
Bonhomme, Vincent
Holzmuller, Philippe
Lemesre, Jean-Loup
Loire, Etienne
Sereno, Denis
Pissarra, Joana
AuthorAffiliation 3 UMR ASTRE, CIRAD, INRAE, University of Montpellier (I-MUSE), Montpellier, France
1 UMR INTERTRYP, IRD, CIRAD, University of Montpellier (I-MUSE), Montpellier, France
4 ISEM, CNRS, EPHE, IRD, University of Montpellier (I-MUSE), Montpellier, France
National Cancer Institute at Frederick, UNITED STATES
2 UMR CBGP, INRAE, CIRAD, IRD, Montpellier SupAgro, University of Montpellier (I-MUSE), Montpellier, France
AuthorAffiliation_xml – name: 3 UMR ASTRE, CIRAD, INRAE, University of Montpellier (I-MUSE), Montpellier, France
– name: 2 UMR CBGP, INRAE, CIRAD, IRD, Montpellier SupAgro, University of Montpellier (I-MUSE), Montpellier, France
– name: 1 UMR INTERTRYP, IRD, CIRAD, University of Montpellier (I-MUSE), Montpellier, France
– name: 4 ISEM, CNRS, EPHE, IRD, University of Montpellier (I-MUSE), Montpellier, France
– name: National Cancer Institute at Frederick, UNITED STATES
Author_xml – sequence: 1
  givenname: Joana
  orcidid: 0000-0002-0506-8042
  surname: Pissarra
  fullname: Pissarra, Joana
– sequence: 2
  givenname: Franck
  surname: Dorkeld
  fullname: Dorkeld, Franck
– sequence: 3
  givenname: Etienne
  surname: Loire
  fullname: Loire, Etienne
– sequence: 4
  givenname: Vincent
  surname: Bonhomme
  fullname: Bonhomme, Vincent
– sequence: 5
  givenname: Denis
  orcidid: 0000-0002-0034-9291
  surname: Sereno
  fullname: Sereno, Denis
– sequence: 6
  givenname: Jean-Loup
  surname: Lemesre
  fullname: Lemesre, Jean-Loup
– sequence: 7
  givenname: Philippe
  surname: Holzmuller
  fullname: Holzmuller, Philippe
BackLink https://hal.inrae.fr/hal-03808360$$DView record in HAL
BookMark eNqNk12L1DAUhousuB_6DwQLgrhgx3w2DYIwLOoODCy4696GNDmdydBpuk276L83dapsl72QXCScPOdNzpuc0-So8Q0kyWuMFpgK_HHnh67R9aKN4QUigjLJniUnWFKS5QTRowfr4-Q0hB1CnBZ5_iI5pjkSiHBykny6Xq1vVx9S3aS-hSYLUdVA2roWatdAWvkuvckM1HUKresjkwaowfTONy-T55WuA7ya5rPkx9cvNxeX2frq2-piuc5MzkmfEYtLYZjgOUiEpeSFkQaVCDAvpADghGIMlpfWQlmIilcgJLLIamMpLSk9S94cdNvaBzXVHRQRGBMmmJCRWB0I6_VOtZ3b6-6X8tqpPwHfbZTuemdqUESChYqVlEvMWIG1tlTmuqSVLXKCIWp9nk4byj1YA03f6XomOt9p3FZt_L2SjGMkRBQ4PwhsH6VdLtdqjCFaoCI-wT2O7PvpsM7fDRB6tXdhdFs34IdDjRTlORldePsIfdqJidroWKxrKh_vaEZRtRQ4Z7SIWKQWT1BxWNg7Ez9U5WJ8lnA-S4hMDz_7jR5CUKvr7__PXt3O2XcP2C3out8GXw_j9wpzkB1A0_kQOqj-OYuRGvvhrxtq7Ac19QP9DQKp-mc
Cites_doi 10.1016/j.jim.2015.03.022
10.1016/j.humimm.2015.11.012
10.1093/nar/gkh435
10.4161/hv.36134
10.1002/eji.201343726
10.1371/journal.pone.0115745
10.1111/j.0105-2896.2005.00307.x
10.4049/jimmunol.178.11.7181
10.4049/jimmunol.160.7.3363
10.1007/s002510050595
10.1038/npjvaccines.2016.9
10.1007/s00251-015-0873-y
10.32614/CRAN.package.tidyverse
10.1111/obr.12605
10.1038/360434a0
10.1016/j.vaccine.2012.01.033
10.4049/jimmunol.165.2.1123
10.32614/CRAN.package.Peptides
10.1111/j.1365-2249.2004.02371.x
10.1186/1471-2105-11-568
10.1093/bioinformatics/btv123
10.1016/j.meegid.2016.10.002
10.1186/1471-2105-13-309
10.2174/138161210793292447
10.1093/bib/bbr060
10.4049/jimmunol.1103008
10.1002/eji.200636783
10.7554/eLife.32402
10.1016/j.vaccine.2008.09.085
10.1111/iji.12214
10.1016/j.coi.2014.01.009
10.1111/j.0105-2896.2005.00301.x
10.1046/j.1365-3024.2000.00331.x
10.4049/jimmunol.1700893
10.1016/j.immuni.2005.05.009
10.1155/2013/521231
10.1016/0022-2836(82)90515-0
10.3389/fimmu.2014.00260
10.1371/journal.pone.0058309
10.1146/annurev-med-051214-024241
10.1186/1472-6750-6-35
10.1038/nrd2224
10.1016/j.micpath.2012.07.002
10.1093/nar/gkw1099
10.1099/vir.0.82826-0
10.1371/journal.pcbi.1003266
10.1098/rsob.120139
10.1093/nar/gkw1105
10.1016/j.vaccine.2015.03.072
10.1016/j.tibtech.2007.12.006
10.1371/journal.ppat.1002759
10.1038/nbt1215
10.1146/annurev.immunol.17.1.51
10.1186/1471-2105-14-211
10.1073/pnas.95.1.270
10.1016/j.immuni.2010.09.017
10.1002/9781118345313
10.1093/nar/gku938
10.1371/journal.pcbi.1000048
10.4049/jimmunol.172.9.5561
10.1016/j.addr.2009.07.001
10.1093/inthealth/ihv002
10.1186/1745-7580-6-S2-S3
10.1002/eji.200535035
ContentType Journal Article
Copyright COPYRIGHT 2022 Public Library of Science
2022 Pissarra et al. This is an open access article distributed under the terms of the Creative Commons Attribution License: http://creativecommons.org/licenses/by/4.0/ (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
licence_http://creativecommons.org/publicdomain/zero
2022 Pissarra et al 2022 Pissarra et al
Copyright_xml – notice: COPYRIGHT 2022 Public Library of Science
– notice: 2022 Pissarra et al. This is an open access article distributed under the terms of the Creative Commons Attribution License: http://creativecommons.org/licenses/by/4.0/ (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
– notice: licence_http://creativecommons.org/publicdomain/zero
– notice: 2022 Pissarra et al 2022 Pissarra et al
DBID AAYXX
CITATION
IOV
ISR
3V.
7QG
7QL
7QO
7RV
7SN
7SS
7T5
7TG
7TM
7U9
7X2
7X7
7XB
88E
8AO
8C1
8FD
8FE
8FG
8FH
8FI
8FJ
8FK
ABJCF
ABUWG
AEUYN
AFKRA
ARAPS
ATCPS
AZQEC
BBNVY
BENPR
BGLVJ
BHPHI
C1K
CCPQU
D1I
DWQXO
FR3
FYUFA
GHDGH
GNUQQ
H94
HCIFZ
K9.
KB.
KB0
KL.
L6V
LK8
M0K
M0S
M1P
M7N
M7P
M7S
NAPCQ
P5Z
P62
P64
PATMY
PDBOC
PHGZM
PHGZT
PIMPY
PJZUB
PKEHL
PPXIY
PQEST
PQGLB
PQQKQ
PQUKI
PRINS
PTHSS
PYCSY
RC3
7X8
1XC
VOOES
5PM
DOA
DOI 10.1371/journal.pone.0273494
DatabaseName CrossRef
Gale In Context: Opposing Viewpoints
Gale In Context: Science
ProQuest Central (Corporate)
Animal Behavior Abstracts
Bacteriology Abstracts (Microbiology B)
Biotechnology Research Abstracts
Nursing & Allied Health Database
Ecology Abstracts
Entomology Abstracts (Full archive)
Immunology Abstracts
Meteorological & Geoastrophysical Abstracts
Nucleic Acids Abstracts
Virology and AIDS Abstracts
Agricultural Science Collection
Health & Medical Collection
ProQuest Central (purchase pre-March 2016)
Medical Database (Alumni Edition)
ProQuest Pharma Collection
Public Health Database
Technology Research Database
ProQuest SciTech Collection
ProQuest Technology Collection
ProQuest Natural Science Collection
ProQuest Hospital Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
Materials Science & Engineering Collection
ProQuest Central (Alumni)
ProQuest One Sustainability
ProQuest Central UK/Ireland
Advanced Technologies & Computer Science Collection
Agricultural & Environmental Science Collection
ProQuest Central Essentials
Biological Science Collection
ProQuest Central
ProQuest Technology Collection
Natural Science Collection
Environmental Sciences and Pollution Management
ProQuest One Community College
ProQuest Materials Science Collection
ProQuest Central
Engineering Research Database
Proquest Health Research Premium Collection
Health Research Premium Collection (Alumni)
ProQuest Central Student
AIDS and Cancer Research Abstracts
SciTech Premium Collection
ProQuest Health & Medical Complete (Alumni)
Materials Science Database
Nursing & Allied Health Database (Alumni Edition)
Meteorological & Geoastrophysical Abstracts - Academic
ProQuest Engineering Collection
Biological Sciences
Agricultural Science Database
ProQuest Health & Medical Collection
PML(ProQuest Medical Library)
Algology Mycology and Protozoology Abstracts (Microbiology C)
Biological Science Database
Engineering Database
Nursing & Allied Health Premium
ProQuest advanced technologies & aerospace journals
ProQuest Advanced Technologies & Aerospace Collection
Biotechnology and BioEngineering Abstracts
Environmental Science Database
Materials Science Collection
ProQuest Central Premium
ProQuest One Academic
ProQuest Publicly Available Content Database
ProQuest Health & Medical Research Collection
ProQuest One Academic Middle East (New)
ProQuest One Health & Nursing
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Applied & Life Sciences
ProQuest One Academic (retired)
ProQuest One Academic UKI Edition
ProQuest Central China
Engineering collection
Environmental Science Collection
Genetics Abstracts
MEDLINE - Academic
Hyper Article en Ligne (HAL)
Hyper Article en Ligne (HAL) (Open Access)
PubMed Central (Full Participant titles)
DOAJ Directory of Open Access Journal Collection
DatabaseTitle CrossRef
Agricultural Science Database
Publicly Available Content Database
ProQuest Central Student
ProQuest Advanced Technologies & Aerospace Collection
ProQuest Central Essentials
Nucleic Acids Abstracts
SciTech Premium Collection
ProQuest Central China
Environmental Sciences and Pollution Management
ProQuest One Applied & Life Sciences
ProQuest One Sustainability
Health Research Premium Collection
Meteorological & Geoastrophysical Abstracts
Natural Science Collection
Health & Medical Research Collection
Biological Science Collection
ProQuest Central (New)
ProQuest Medical Library (Alumni)
Engineering Collection
Advanced Technologies & Aerospace Collection
Engineering Database
Virology and AIDS Abstracts
ProQuest Biological Science Collection
ProQuest One Academic Eastern Edition
Agricultural Science Collection
ProQuest Hospital Collection
ProQuest Technology Collection
Health Research Premium Collection (Alumni)
Biological Science Database
Ecology Abstracts
ProQuest Hospital Collection (Alumni)
Biotechnology and BioEngineering Abstracts
Environmental Science Collection
Entomology Abstracts
Nursing & Allied Health Premium
ProQuest Health & Medical Complete
ProQuest One Academic UKI Edition
Environmental Science Database
ProQuest Nursing & Allied Health Source (Alumni)
Engineering Research Database
ProQuest One Academic
Meteorological & Geoastrophysical Abstracts - Academic
ProQuest One Academic (New)
Technology Collection
Technology Research Database
ProQuest One Academic Middle East (New)
Materials Science Collection
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
ProQuest One Community College
ProQuest One Health & Nursing
ProQuest Natural Science Collection
ProQuest Pharma Collection
ProQuest Central
ProQuest Health & Medical Research Collection
Genetics Abstracts
ProQuest Engineering Collection
Biotechnology Research Abstracts
Health and Medicine Complete (Alumni Edition)
ProQuest Central Korea
Bacteriology Abstracts (Microbiology B)
Algology Mycology and Protozoology Abstracts (Microbiology C)
Agricultural & Environmental Science Collection
AIDS and Cancer Research Abstracts
Materials Science Database
ProQuest Materials Science Collection
ProQuest Public Health
ProQuest Nursing & Allied Health Source
ProQuest SciTech Collection
Advanced Technologies & Aerospace Database
ProQuest Medical Library
Animal Behavior Abstracts
Materials Science & Engineering Collection
Immunology Abstracts
ProQuest Central (Alumni)
MEDLINE - Academic
DatabaseTitleList



Agricultural Science Database

CrossRef
MEDLINE - Academic

Database_xml – sequence: 1
  dbid: DOA
  name: DOAJ Directory of Open Access Journals
  url: https://www.doaj.org/
  sourceTypes: Open Website
– sequence: 2
  dbid: PIMPY
  name: ProQuest Publicly Available Content Database
  url: http://search.proquest.com/publiccontent
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Sciences (General)
Computer Science
DocumentTitleAlternate SILVI, an open-source pipeline for T-cell epitope selection
EISSN 1932-6203
ExternalDocumentID 2711247479
oai_doaj_org_article_29edef4b35914481aad396ab3fd8621e
PMC9451077
oai:HAL:hal-03808360v1
A716438747
10_1371_journal_pone_0273494
GeographicLocations France
GeographicLocations_xml – name: France
GrantInformation_xml – fundername: ;
– fundername: ;
  grantid: 642609
– fundername: ;
  grantid: ANR-11-LABX-0024-PARAFRAP
GroupedDBID ---
123
29O
2WC
53G
5VS
7RV
7X2
7X7
7XC
88E
8AO
8C1
8CJ
8FE
8FG
8FH
8FI
8FJ
A8Z
AAFWJ
AAUCC
AAWOE
AAYXX
ABDBF
ABIVO
ABJCF
ABUWG
ACCTH
ACGFO
ACIHN
ACIWK
ACPRK
ACUHS
ADBBV
AEAQA
AENEX
AEUYN
AFFHD
AFKRA
AFPKN
AFRAH
AHMBA
ALMA_UNASSIGNED_HOLDINGS
AOIJS
APEBS
ARAPS
ATCPS
BAIFH
BAWUL
BBNVY
BBTPI
BCNDV
BENPR
BGLVJ
BHPHI
BKEYQ
BPHCQ
BVXVI
BWKFM
CCPQU
CITATION
CS3
D1I
D1J
D1K
DIK
DU5
E3Z
EAP
EAS
EBD
EMOBN
ESX
EX3
F5P
FPL
FYUFA
GROUPED_DOAJ
GX1
HCIFZ
HH5
HMCUK
HYE
IAO
IEA
IGS
IHR
IHW
INH
INR
IOV
IPY
ISE
ISR
ITC
K6-
KB.
KQ8
L6V
LK5
LK8
M0K
M1P
M48
M7P
M7R
M7S
M~E
NAPCQ
O5R
O5S
OK1
OVT
P2P
P62
PATMY
PDBOC
PHGZM
PHGZT
PIMPY
PJZUB
PPXIY
PQGLB
PQQKQ
PROAC
PSQYO
PTHSS
PV9
PYCSY
RNS
RPM
RZL
SV3
TR2
UKHRP
WOQ
WOW
~02
~KM
ALIPV
BBORY
3V.
7QG
7QL
7QO
7SN
7SS
7T5
7TG
7TM
7U9
7XB
8FD
8FK
AZQEC
C1K
DWQXO
ESTFP
FR3
GNUQQ
H94
K9.
KL.
M7N
P64
PKEHL
PQEST
PQUKI
PRINS
RC3
7X8
1XC
VOOES
5PM
AAPBV
ABPTK
BBAFP
N95
ID FETCH-LOGICAL-c652t-2d1b7c4756e9019958c9c0b0e15897ee52311ed5bddeb87f5fe790d0dacd33b33
IEDL.DBID FPL
ISICitedReferencesCount 0
ISICitedReferencesURI http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000933379100025&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
ISSN 1932-6203
IngestDate Mon Dec 05 23:08:03 EST 2022
Fri Oct 03 12:28:27 EDT 2025
Tue Nov 04 01:59:47 EST 2025
Thu Nov 06 12:50:01 EST 2025
Sun Nov 09 11:57:40 EST 2025
Tue Oct 07 07:51:16 EDT 2025
Sat Nov 29 13:04:32 EST 2025
Sat Nov 29 10:11:32 EST 2025
Wed Nov 26 10:02:16 EST 2025
Wed Nov 26 10:24:27 EST 2025
Thu May 22 21:23:34 EDT 2025
Sat Nov 29 04:08:28 EST 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 9
Language English
License licence_http://creativecommons.org/publicdomain/zero/: http://creativecommons.org/publicdomain/zero
This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Creative Commons Attribution License
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c652t-2d1b7c4756e9019958c9c0b0e15897ee52311ed5bddeb87f5fe790d0dacd33b33
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
Competing Interests: The authors declare no competing interests exist.
ORCID 0000-0002-0034-9291
0000-0002-0506-8042
0000-0001-8447-9730
0000-0002-2742-6349
0000-0002-8919-9081
OpenAccessLink http://dx.doi.org/10.1371/journal.pone.0273494
PMID 36070252
PQID 2711247479
PQPubID 1436336
PageCount e0273494
ParticipantIDs plos_journals_2711247479
doaj_primary_oai_doaj_org_article_29edef4b35914481aad396ab3fd8621e
pubmedcentral_primary_oai_pubmedcentral_nih_gov_9451077
hal_primary_oai_HAL_hal_03808360v1
proquest_miscellaneous_2711306623
proquest_journals_2711247479
gale_infotracmisc_A716438747
gale_infotracacademiconefile_A716438747
gale_incontextgauss_ISR_A716438747
gale_incontextgauss_IOV_A716438747
gale_healthsolutions_A716438747
crossref_primary_10_1371_journal_pone_0273494
PublicationCentury 2000
PublicationDate 2022-09-07
PublicationDateYYYYMMDD 2022-09-07
PublicationDate_xml – month: 09
  year: 2022
  text: 2022-09-07
  day: 07
PublicationDecade 2020
PublicationPlace San Francisco
PublicationPlace_xml – name: San Francisco
– name: San Francisco, CA USA
PublicationTitle PloS one
PublicationYear 2022
Publisher Public Library of Science
Public Library of Science (PLoS)
Publisher_xml – name: Public Library of Science
– name: Public Library of Science (PLoS)
References T Hagan (pone.0273494.ref016) 2015; 33
R Vita (pone.0273494.ref014) 2015; 43
L Zhang (pone.0273494.ref031) 2012; 13
JJA Calis (pone.0273494.ref012) 2013; 9
V Jurtz (pone.0273494.ref068) 2017; 199
H-G Rammensee (pone.0273494.ref070) 1999; 50
A Sette (pone.0273494.ref035) 2010; 33
CA Weber (pone.0273494.ref044) 2009; 61
V Dutoit (pone.0273494.ref056) 2005; 35
V. Desai D (pone.0273494.ref027) 2014
M Castelli (pone.0273494.ref034) 2013; 2013
KP Burke (pone.0273494.ref049) 2012; 188
R Axelsson-Robertson (pone.0273494.ref053) 2013; 8
M Pinder (pone.0273494.ref058) 2004; 135
A Bateman (pone.0273494.ref064) 2017; 45
A Patronov (pone.0273494.ref005) 2013; 3
M Wang (pone.0273494.ref072) 2014
T. Aebischer (pone.0273494.ref036) 2014; 5
D Serruto (pone.0273494.ref002) 2012; 30
C Lundegaard (pone.0273494.ref024) 2010; 6
M Moutaftsi (pone.0273494.ref069) 2006; 24
J Kyte (pone.0273494.ref073) 1982; 157
AW Purcell (pone.0273494.ref008) 2007; 6
JW Yewdell (pone.0273494.ref037) 1999; 17
S Southwood (pone.0273494.ref060) 1998; 160
KL Rock (pone.0273494.ref041) 2005; 207
C Neumann-Haefelin (pone.0273494.ref048) 2007; 88
AVS Hill (pone.0273494.ref052) 1992; 360
SH Kaufmann (pone.0273494.ref015) 2014; 28
P Wang (pone.0273494.ref030) 2010; 11
pone.0273494.ref007
T Trolle (pone.0273494.ref062) 2015; 31
S Vivona (pone.0273494.ref023) 2008; 26
S Vivona (pone.0273494.ref018) 2006; 6
P Holzmuller (pone.0273494.ref021) 2016; 45
SJ Goodswen (pone.0273494.ref004) 2014; 9
Y He (pone.0273494.ref019) 2010; 297505
P Wang (pone.0273494.ref033) 2008; 4
DL Doolan (pone.0273494.ref059) 2000; 165
A Lalvani (pone.0273494.ref054) 1998; 95
FA Castelli (pone.0273494.ref057) 2007; 37
SP Singh (pone.0273494.ref029) 2016; 77
M Andreatta (pone.0273494.ref071) 2015; 67
NL Dudek (pone.0273494.ref010) 2010; 16
AS De Groot (pone.0273494.ref042) 2015; 10
AJ Sant (pone.0273494.ref039) 2005; 207
S Paul (pone.0273494.ref013) 2014; 191
V Jaiswal (pone.0273494.ref017) 2013; 14
L Liljeroos (pone.0273494.ref025) 2015; 156241
CA Lazarski (pone.0273494.ref038) 2005; 23
L Backert (pone.0273494.ref006) 2015
DM Resende (pone.0273494.ref040) 2012; 13
H Nagai (pone.0273494.ref061) 2014
C Aurrecoechea (pone.0273494.ref063) 2017; 45
R Wang (pone.0273494.ref050) 2004; 172
JM González (pone.0273494.ref051) 2000; 22
P Oyarzun (pone.0273494.ref011) 2015; 42
J Min (pone.0273494.ref022) 2018; 19
S Paul (pone.0273494.ref074) 2015; 422
Y Wang (pone.0273494.ref055) 2012; 53
A Ferrante (pone.0273494.ref032) 2007; 178
S Noazin (pone.0273494.ref043) 2008; 26
pone.0273494.ref065
SK Dhanda (pone.0273494.ref001) 2017; 18
J Settleman (pone.0273494.ref009) 2018; 7
pone.0273494.ref066
pone.0273494.ref067
PJ Hotez (pone.0273494.ref003) 2016; 67
pone.0273494.ref028
F Legoux (pone.0273494.ref046) 2013; 43
AI Heinson (pone.0273494.ref020) 2015; 7
D Franceschini (pone.0273494.ref047) 2012; 8
S McGinnis (pone.0273494.ref045) 2004; 32
N Tomar (pone.0273494.ref026) 2014
References_xml – volume: 422
  start-page: 28
  year: 2015
  ident: pone.0273494.ref074
  article-title: Development and validation of a broad scheme for prediction of HLA class II restricted T cell epitopes
  publication-title: J Immunol Methods
  doi: 10.1016/j.jim.2015.03.022
– volume: 77
  start-page: 295
  year: 2016
  ident: pone.0273494.ref029
  article-title: Major histocompatibility complex linked databases and prediction tools for designing vaccines
  publication-title: Hum Immunol
  doi: 10.1016/j.humimm.2015.11.012
– volume: 32
  start-page: W20
  year: 2004
  ident: pone.0273494.ref045
  article-title: BLAST: At the core of a powerful and diverse set of sequence analysis tools
  publication-title: Nucleic Acids Res
  doi: 10.1093/nar/gkh435
– volume-title: Immunoinformatics. Methods in Molecular Biology (Methods and Protocols)
  year: 2014
  ident: pone.0273494.ref026
– volume: 10
  start-page: 3570
  year: 2015
  ident: pone.0273494.ref042
  article-title: Immune camouflage: Relevance to vaccines and human immunology
  publication-title: Hum Vaccin Immunother
  doi: 10.4161/hv.36134
– volume: 43
  start-page: 3244
  year: 2013
  ident: pone.0273494.ref046
  article-title: Characterization of the human CD4+ T-cell repertoire specific for major histocompatibility class I-restricted antigens
  publication-title: Eur J Immunol
  doi: 10.1002/eji.201343726
– volume: 9
  start-page: e115745
  year: 2014
  ident: pone.0273494.ref004
  article-title: Enhancing in silico protein-based vaccine discovery for eukaryotic pathogens using predicted peptide-MHC binding and peptide conservation scores
  publication-title: PLoS One
  doi: 10.1371/journal.pone.0115745
– volume: 207
  start-page: 261
  year: 2005
  ident: pone.0273494.ref039
  article-title: The relationship between immunodominance, DM editing, and the kinetic stability of MHC class II:peptide complexes
  publication-title: Immunol Rev
  doi: 10.1111/j.0105-2896.2005.00307.x
– volume: 178
  start-page: 7181
  year: 2007
  ident: pone.0273494.ref032
  article-title: Cooperativity of hydrophobic anchor interactions: evidence for epitope selection by MHC class II as a folding process
  publication-title: J Immunol
  doi: 10.4049/jimmunol.178.11.7181
– volume: 160
  start-page: 3363
  year: 1998
  ident: pone.0273494.ref060
  article-title: Several common HLA-DR types share largely overlapping peptide binding repertoires
  publication-title: J Immunol
  doi: 10.4049/jimmunol.160.7.3363
– volume: 50
  start-page: 213
  year: 1999
  ident: pone.0273494.ref070
  article-title: SYFPEITHI: database for MHC ligands and peptide motifs
  publication-title: Immunogenetics
  doi: 10.1007/s002510050595
– ident: pone.0273494.ref007
  doi: 10.1038/npjvaccines.2016.9
– volume: 67
  start-page: 641
  year: 2015
  ident: pone.0273494.ref071
  article-title: Accurate pan-specific prediction of peptide-MHC class II binding affinity with improved binding core identification
  publication-title: Immunogenetics
  doi: 10.1007/s00251-015-0873-y
– ident: pone.0273494.ref065
  doi: 10.32614/CRAN.package.tidyverse
– volume: 19
  start-page: 49
  year: 2018
  ident: pone.0273494.ref022
  article-title: Double burden of diseases worldwide: coexistence of undernutrition and overnutrition-related non-communicable chronic diseases
  publication-title: Obes Rev
  doi: 10.1111/obr.12605
– volume: 360
  start-page: 434
  year: 1992
  ident: pone.0273494.ref052
  article-title: Molecular analysis of the association of HLA-B53 and resistance to severe malaria
  publication-title: Nature
  doi: 10.1038/360434a0
– volume: 30
  start-page: B87
  year: 2012
  ident: pone.0273494.ref002
  article-title: The new multicomponent vaccine against meningococcal serogroup B, 4CMenB: Immunological, functional and structural characterization of the antigens
  publication-title: Vaccine
  doi: 10.1016/j.vaccine.2012.01.033
– volume: 165
  start-page: 1123
  year: 2000
  ident: pone.0273494.ref059
  article-title: HLA-DR-Promiscuous T Cell Epitopes from Plasmodium falciparum Pre-Erythrocytic-Stage Antigens Restricted by Multiple HLA Class II Alleles
  publication-title: J Immunol
  doi: 10.4049/jimmunol.165.2.1123
– ident: pone.0273494.ref067
  doi: 10.32614/CRAN.package.Peptides
– volume: 135
  start-page: 286
  year: 2004
  ident: pone.0273494.ref058
  article-title: Cellular immunity induced by the recombinant Plasmodium falciparum malaria vaccine, RTS,S/AS02, in semi-immune adults in The Gambia
  publication-title: Clin Exp Immunol
  doi: 10.1111/j.1365-2249.2004.02371.x
– volume: 11
  start-page: 568
  year: 2010
  ident: pone.0273494.ref030
  article-title: Peptide binding predictions for HLA DR, DP and DQ molecules
  publication-title: BMC Bioinformatics
  doi: 10.1186/1471-2105-11-568
– volume: 31
  start-page: 2174
  year: 2015
  ident: pone.0273494.ref062
  article-title: Automated benchmarking of peptide-MHC class I binding predictions
  publication-title: Bioinformatics
  doi: 10.1093/bioinformatics/btv123
– volume: 45
  start-page: 426
  year: 2016
  ident: pone.0273494.ref021
  article-title: The transcriptomic analytical level determines the human monocyte-derived macrophage response toward either the infectious agent or the host
  publication-title: Infect Genet Evol
  doi: 10.1016/j.meegid.2016.10.002
– volume: 13
  start-page: 309
  year: 2012
  ident: pone.0273494.ref040
  article-title: An assessment on epitope prediction methods for protozoa genomes
  publication-title: BMC Bioinformatics
  doi: 10.1186/1471-2105-13-309
– volume: 16
  start-page: 3149
  year: 2010
  ident: pone.0273494.ref010
  article-title: Epitope discovery and their use in peptide based vaccines
  publication-title: Curr Pharm Des
  doi: 10.2174/138161210793292447
– volume: 13
  start-page: 350
  year: 2012
  ident: pone.0273494.ref031
  article-title: Toward more accurate pan-specific MHC-peptide binding prediction: A review of current methods and tools
  publication-title: Brief Bioinform
  doi: 10.1093/bib/bbr060
– volume: 188
  start-page: 5177
  year: 2012
  ident: pone.0273494.ref049
  article-title: Immunogenicity and Cross-Reactivity of a Representative Ancestral Sequence in Hepatitis C Virus Infection
  publication-title: J Immunol
  doi: 10.4049/jimmunol.1103008
– volume: 37
  start-page: 1513
  year: 2007
  ident: pone.0273494.ref057
  article-title: Differential capacity of T cell priming in naive donors of promiscuous CD4+ T cell epitopes of HCV NS3 and Core proteins
  publication-title: Eur J Immunol
  doi: 10.1002/eji.200636783
– volume: 7
  start-page: e32402
  year: 2018
  ident: pone.0273494.ref009
  article-title: Challenges in validating candidate therapeutic targets in cancer
  publication-title: Elife
  doi: 10.7554/eLife.32402
– volume-title: Immunoinformatics Methods in Molecular Biology (Methods and Protocols)
  year: 2014
  ident: pone.0273494.ref027
– volume: 26
  start-page: 6759
  year: 2008
  ident: pone.0273494.ref043
  article-title: First generation leishmaniasis vaccines: A review of field efficacy trials
  publication-title: Vaccine
  doi: 10.1016/j.vaccine.2008.09.085
– start-page: 309
  volume-title: Immunoinformatics Methods in Molecular Biology (Methods and Protocols)
  year: 2014
  ident: pone.0273494.ref072
– start-page: 2014
  year: 2014
  ident: pone.0273494.ref061
  article-title: Immunological responses and epitope mapping by tuberculosis-associated antigens within the RD1 region in Japanese patients
  publication-title: J Immunol Res
– volume: 42
  start-page: 313
  year: 2015
  ident: pone.0273494.ref011
  article-title: Computer-aided design of T-cell epitope-based vaccines: addressing population coverage
  publication-title: Int J Immunogenet
  doi: 10.1111/iji.12214
– volume: 28
  start-page: 18
  year: 2014
  ident: pone.0273494.ref015
  article-title: Challenges and responses in human vaccine development
  publication-title: Curr Opin Immunol
  doi: 10.1016/j.coi.2014.01.009
– volume: 207
  start-page: 166
  year: 2005
  ident: pone.0273494.ref041
  article-title: Cross-presentation: underlying mechanisms and role in immune surveillance
  publication-title: Immunol Rev
  doi: 10.1111/j.0105-2896.2005.00301.x
– volume: 22
  start-page: 501
  year: 2000
  ident: pone.0273494.ref051
  article-title: HLA-A*0201 restricted CD8+ T-lymphocyte responses to malaria: Identification of new Plasmodium falciparum epitopes by IFN-γ ELISPOT
  publication-title: Parasite Immunol
  doi: 10.1046/j.1365-3024.2000.00331.x
– volume: 199
  start-page: 3360
  year: 2017
  ident: pone.0273494.ref068
  article-title: NetMHCpan-4.0: Improved Peptide–MHC Class I Interaction Predictions Integrating Eluted Ligand and Peptide Binding Affinity Data
  publication-title: J Immunol
  doi: 10.4049/jimmunol.1700893
– start-page: 1
  year: 2015
  ident: pone.0273494.ref006
  article-title: Immunoinformatics and epitope prediction in the age of next-generation sequencing and personalized medicine
  publication-title: Genome Med
– volume: 23
  start-page: 29
  year: 2005
  ident: pone.0273494.ref038
  article-title: The kinetic stability of MHC class II:peptide complexes is a key parameter that dictates immunodominance
  publication-title: Immunity
  doi: 10.1016/j.immuni.2005.05.009
– volume: 2013
  year: 2013
  ident: pone.0273494.ref034
  article-title: Peptide-based vaccinology: experimental and computational approaches to target hypervariable viruses through the fine characterization of protective epitopes recognized by monoclonal antibodies and the identification of T-cell-activating peptides
  publication-title: Clin Dev Immunol
  doi: 10.1155/2013/521231
– ident: pone.0273494.ref066
– volume: 297505
  year: 2010
  ident: pone.0273494.ref019
  article-title: Vaxign: The first web-based vaccine design program for reverse vaccinology and applications for vaccine development
  publication-title: J Biomed Biotechnol
– volume: 157
  start-page: 105
  year: 1982
  ident: pone.0273494.ref073
  article-title: A simple method for displaying the hydropathic character of a protein
  publication-title: J Mol Biol
  doi: 10.1016/0022-2836(82)90515-0
– volume: 5
  start-page: 260
  year: 2014
  ident: pone.0273494.ref036
  article-title: Leishmania spp. Proteome Data Sets: A Comprehensive Resource for Vaccine Development to Target Visceral Leishmaniasis
  publication-title: Front Immunol
  doi: 10.3389/fimmu.2014.00260
– volume: 8
  year: 2013
  ident: pone.0273494.ref053
  article-title: A Broad Profile of Co-Dominant Epitopes Shapes the Peripheral Mycobacterium tuberculosis Specific CD8+ T-Cell Immune Response in South African Patients with Active Tuberculosis
  publication-title: PLoS One
  doi: 10.1371/journal.pone.0058309
– volume: 67
  start-page: 405
  year: 2016
  ident: pone.0273494.ref003
  article-title: New Vaccines for the World’s Poorest People
  publication-title: Annu Rev Med
  doi: 10.1146/annurev-med-051214-024241
– volume: 6
  start-page: 35
  year: 2006
  ident: pone.0273494.ref018
  article-title: NERVE: New Enhanced Reverse Vaccinology Environment
  publication-title: BMC Biotechnol
  doi: 10.1186/1472-6750-6-35
– volume: 6
  start-page: 404
  year: 2007
  ident: pone.0273494.ref008
  article-title: More than one reason to rethink the use of peptides in vaccine design
  publication-title: Nat Rev Drug Discov
  doi: 10.1038/nrd2224
– volume: 53
  start-page: 162
  year: 2012
  ident: pone.0273494.ref055
  article-title: Weak binder for MHC molecule is a potent Mycobacterium tuberculosis-specific CTL epitope in the context of HLA-A24 allele
  publication-title: Microb Pathog
  doi: 10.1016/j.micpath.2012.07.002
– volume: 18
  start-page: 467
  year: 2017
  ident: pone.0273494.ref001
  article-title: Novel in silico tools for designing peptide-based subunit vaccines and immunotherapeutics
  publication-title: Brief Bioinform
– volume: 45
  start-page: D158
  year: 2017
  ident: pone.0273494.ref064
  article-title: UniProt: the universal protein knowledgebase
  publication-title: Nucleic Acids Res
  doi: 10.1093/nar/gkw1099
– volume: 88
  start-page: 1986
  year: 2007
  ident: pone.0273494.ref048
  article-title: Absence of viral escape within a frequently recognized HLA-A26-restricted CD8+ T-cell epitope targeting the functionally constrained hepatitis C virus NS5A/5B cleavage site
  publication-title: J Gen Virol
  doi: 10.1099/vir.0.82826-0
– volume: 9
  start-page: e1003266
  year: 2013
  ident: pone.0273494.ref012
  article-title: Properties of MHC Class I Presented Peptides That Enhance Immunogenicity
  publication-title: PLoS Comput Biol
  doi: 10.1371/journal.pcbi.1003266
– volume: 3
  start-page: 120139
  year: 2013
  ident: pone.0273494.ref005
  article-title: T-cell epitope vaccine design by immunoinformatics
  publication-title: Open Biol
  doi: 10.1098/rsob.120139
– volume: 45
  start-page: D581
  year: 2017
  ident: pone.0273494.ref063
  article-title: EuPathDB: the eukaryotic pathogen genomics database resource
  publication-title: Nucleic Acids Res
  doi: 10.1093/nar/gkw1105
– volume: 33
  start-page: 5294
  year: 2015
  ident: pone.0273494.ref016
  article-title: Systems vaccinology: Enabling rational vaccine design with systems biological approaches
  publication-title: Vaccine
  doi: 10.1016/j.vaccine.2015.03.072
– volume: 26
  start-page: 190
  year: 2008
  ident: pone.0273494.ref023
  article-title: Computer-aided biotechnology: from immuno-informatics to reverse vaccinology
  publication-title: Trends Biotechnol
  doi: 10.1016/j.tibtech.2007.12.006
– volume: 8
  start-page: e1002759
  year: 2012
  ident: pone.0273494.ref047
  article-title: Polyfunctional type-1, -2, and -17 CD8+ T cell responses to apoptotic self-antigens correlate with the chronic evolution of hepatitis C virus infection
  publication-title: PLoS Pathog
  doi: 10.1371/journal.ppat.1002759
– volume: 24
  start-page: 817
  year: 2006
  ident: pone.0273494.ref069
  article-title: A consensus epitope prediction approach identifies the breadth of murine TCD8+-cell responses to vaccinia virus
  publication-title: Nat Biotechnol
  doi: 10.1038/nbt1215
– volume: 17
  start-page: 51
  year: 1999
  ident: pone.0273494.ref037
  article-title: Immunodominance in major histocompatibility complex class I–restricted T lymphocyte responses
  publication-title: Annu Rev Immunol
  doi: 10.1146/annurev.immunol.17.1.51
– volume: 156241
  year: 2015
  ident: pone.0273494.ref025
  article-title: Structural and Computational Biology in the Design of Immunogenic Vaccine Antigens
  publication-title: J Immunol Res
– volume: 14
  start-page: 211
  year: 2013
  ident: pone.0273494.ref017
  article-title: Jenner-predict server: prediction of protein vaccine candidates (PVCs) in bacteria based on host-pathogen interactions
  publication-title: BMC Bioinformatics
  doi: 10.1186/1471-2105-14-211
– volume: 95
  start-page: 270
  year: 1998
  ident: pone.0273494.ref054
  article-title: Human cytolytic and interferon γ-secreting CD8+ T lymphocytes specific for Mycobacterium tuberculosis
  publication-title: Proc Natl Acad Sci U S A
  doi: 10.1073/pnas.95.1.270
– volume: 33
  start-page: 530
  year: 2010
  ident: pone.0273494.ref035
  article-title: Reverse Vaccinology: Developing Vaccines in the Era of Genomics
  publication-title: Immunity
  doi: 10.1016/j.immuni.2010.09.017
– ident: pone.0273494.ref028
  doi: 10.1002/9781118345313
– volume: 191
  start-page: 6
  year: 2014
  ident: pone.0273494.ref013
  publication-title: HLA class I alleles are associated with peptide binding repertoires of different size, affinity and immunogenicity
– volume: 43
  start-page: D405
  year: 2015
  ident: pone.0273494.ref014
  article-title: The immune epitope database (IEDB) 3.0
  publication-title: Nucleic Acids Res
  doi: 10.1093/nar/gku938
– volume: 4
  start-page: e1000048
  year: 2008
  ident: pone.0273494.ref033
  article-title: A Systematic Assessment of MHC Class II Peptide Binding Predictions and Evaluation of a Consensus Approach
  publication-title: PLoS Comput Biol
  doi: 10.1371/journal.pcbi.1000048
– volume: 172
  start-page: 5561
  year: 2004
  ident: pone.0273494.ref050
  article-title: Induction in Humans of CD8 + and CD4 + T Cell and Antibody Responses by Sequential Immunization with Malaria DNA and Recombinant Protein
  publication-title: J Immunol
  doi: 10.4049/jimmunol.172.9.5561
– volume: 61
  start-page: 965
  year: 2009
  ident: pone.0273494.ref044
  article-title: T cell epitope: Friend or Foe? Immunogenicity of biologics in context
  publication-title: Adv Drug Deliv Rev
  doi: 10.1016/j.addr.2009.07.001
– volume: 7
  start-page: 85
  year: 2015
  ident: pone.0273494.ref020
  article-title: The promise of reverse vaccinology
  publication-title: Int Health
  doi: 10.1093/inthealth/ihv002
– volume: 6
  start-page: S3
  year: 2010
  ident: pone.0273494.ref024
  article-title: State of the art and challenges in sequence based T-cell epitope prediction
  publication-title: Immunome Res
  doi: 10.1186/1745-7580-6-S2-S3
– volume: 35
  start-page: 3493
  year: 2005
  ident: pone.0273494.ref056
  article-title: Differences in HCV-specific T cell responses between chronic HCV infection and HIV/HCV co-infection
  publication-title: Eur J Immunol
  doi: 10.1002/eji.200535035
SSID ssj0053866
Score 2.3989537
Snippet High-throughput screening of available genomic data and identification of potential antigenic candidates have promoted the development of epitope-based...
SourceID plos
doaj
pubmedcentral
hal
proquest
gale
crossref
SourceType Open Website
Open Access Repository
Aggregation Database
Index Database
StartPage e0273494
SubjectTerms Algorithms
Analysis
Antigenic determinants
Antigens
Binding
Biochemistry, Molecular Biology
Bioinformatics
Biology and Life Sciences
Chemical properties
Computer Science
Epitopes
Evaluation
Fluid filters
Genomes
Genomics
Health aspects
Hepatitis C
High-throughput screening
Histocompatibility antigen HLA
Human papillomavirus
Hydrophobicity
Immunogenicity
Immunotherapy
Leukocytes
Life Sciences
Localization
Lymphocytes T
Medicine and Health Sciences
Microorganisms
Modeling and Simulation
Pathogens
Peptides
Predictions
Proteins
Proteomes
Public software
Research and Analysis Methods
T cells
Tuberculosis
Vaccines
Workflow
SummonAdditionalLinks – databaseName: DOAJ Directory of Open Access Journal Collection
  dbid: DOA
  link: http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Lb9QwELZgxYELojzUlAIBIQESaePYjm1xWhBVV1oVREvVm2UnNrsSykbNbn8_M0l2VUtIcOAaT17feMYzycxnQt6UgknLrciEhUyHh0Azp6nLeFFLz7UM1Pc8s3N5dqaurvS3W1t9YU3YQA88AHdcaF_7wB0TGmJ_Ra2tmS6tY6GGYJx69L4Q9WyTqcEHgxWX5dgoxyQ9HvVy1K4af9QzumgeLUQ9X__OK99dYFHkpP216qLAMy6bvLUOnTwkD8YAMp0OD75H7vjmEdkbTbRL34080u8fk4_ns_nl7ENqmxT3yMqG7_Rpu2yxB92nEK6mFxl-uU99C4bd-rTrd8UBVT0hP06-XHw-zca9ErKqFMU6K2rqZMWlKD2s8FoLVekqd7mnQmnpPeSblPpaOHBnTskggpc6r_PaVjVjjrGnZNIAOvskVVaDykIlXKW4UMExyzHvg9BCw0JXJiTbAmfagRLD9P_FJKQSAwgGgTYj0An5hOjuZJHQuj8Aajajms3f1JyQl6gbM3SH7szSTDHfYwqSooS87iWQ1KLBqpmfdtN1Zvb18h-Ezr9HQm9HobACRVd27FSAd0KyrEjyMJIE06ziuy0QjFsvfjqdGzyWM4W84PkNTcg-TrQtdJ0pJMTAHE7XcPnt5Pvz8KvdMN4Zy-Uav9oMMgy5_VlCZDRpo4eJR5rloqcX1xz8tJQH_0Ntz8j9AvtF8A-cPCST9fXGPyf3qpv1srt-0dvsb-yDRNY
  priority: 102
  providerName: Directory of Open Access Journals
– databaseName: ProQuest advanced technologies & aerospace journals
  dbid: P5Z
  link: http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV3db9MwELdY4YEXYHxoYQMCQgIkssWxHcfiARXEtErVmNiYJl4sO3HWSijJmnZ_P3eJWxYJISRe41Nd35fv7PPvCHmdCiYNNyISBjIdXpY0soraiCeFdFzJkroOZ3Yqj4-ziwt14g_cWl9WufaJnaMu6hzPyA8SCZEBh-BXfWyuIuwahbervoXGFrmNKAlomCfix9oTgy2nqX8uxyQ98NLZb-rK7Xe4LooPtqMOtX_jm7dmWBo5an7W7SD8HBZP3tiNDu__7zoekHs-Dg3HveJsk1uueki2vaW34VsPR_3uEflwOpmeT96Hpgqx1VbUH_eHzbzBp-wuhKg3PIvwAiB0DfiHxoVt11wHJP6YfD_8cvb5KPItF6I8FckySgpqZc6lSB0ECkqJLFd5bGNHRaakc5C2UuoKYcEr2kyWonRSxUVcmLxgzDL2hIwqYO8OCTOjQPJlLmyecZGVlhmO6SNEKAr2yzQg0ZrzuumRNXR3vSYhI-mZoFFS2ksqIJ9QPBtaxMXuPtSLS-3NTCfKFa7klgkFmWJGjSmYSo1lZQGpG3UBeYHC1f0j04116zGmjSwDsQTkVUeB2BgVFt9cmlXb6snX838gOv02IHrjicoaNCU3_sEDrAkxtwaUewNKsPB8ONsMmXFj4UfjqcZvMcsQXjy-pgHZQU1ds67VvxUNfn6tin8efrkZxpmx6q5y9aqnYdgigAVEDrR-8GeGI9V81qGUKw7uXsqnf598l9xN8EEJXtHJPTJaLlbuGbmTXy_n7eJ5Z86_AOkOUok
  priority: 102
  providerName: ProQuest
Title SILVI, an open-source pipeline for T-cell epitope selection
URI https://www.proquest.com/docview/2711247479
https://www.proquest.com/docview/2711306623
https://hal.inrae.fr/hal-03808360
https://pubmed.ncbi.nlm.nih.gov/PMC9451077
https://doaj.org/article/29edef4b35914481aad396ab3fd8621e
http://dx.doi.org/10.1371/journal.pone.0273494
Volume 17
WOSCitedRecordID wos000933379100025&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
journalDatabaseRights – providerCode: PRVAON
  databaseName: DOAJ Directory of Open Access Journals
  customDbUrl:
  eissn: 1932-6203
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0053866
  issn: 1932-6203
  databaseCode: DOA
  dateStart: 20060101
  isFulltext: true
  titleUrlDefault: https://www.doaj.org/
  providerName: Directory of Open Access Journals
– providerCode: PRVHPJ
  databaseName: ROAD: Directory of Open Access Scholarly Resources
  customDbUrl:
  eissn: 1932-6203
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0053866
  issn: 1932-6203
  databaseCode: M~E
  dateStart: 20060101
  isFulltext: true
  titleUrlDefault: https://road.issn.org
  providerName: ISSN International Centre
– providerCode: PRVPQU
  databaseName: Advanced Technologies & Aerospace Database
  customDbUrl:
  eissn: 1932-6203
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0053866
  issn: 1932-6203
  databaseCode: P5Z
  dateStart: 20061201
  isFulltext: true
  titleUrlDefault: https://search.proquest.com/hightechjournals
  providerName: ProQuest
– providerCode: PRVPQU
  databaseName: Agricultural Science Database
  customDbUrl:
  eissn: 1932-6203
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0053866
  issn: 1932-6203
  databaseCode: M0K
  dateStart: 20061201
  isFulltext: true
  titleUrlDefault: https://search.proquest.com/agriculturejournals
  providerName: ProQuest
– providerCode: PRVPQU
  databaseName: Biological Science Database
  customDbUrl:
  eissn: 1932-6203
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0053866
  issn: 1932-6203
  databaseCode: M7P
  dateStart: 20061201
  isFulltext: true
  titleUrlDefault: http://search.proquest.com/biologicalscijournals
  providerName: ProQuest
– providerCode: PRVPQU
  databaseName: Engineering Database
  customDbUrl:
  eissn: 1932-6203
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0053866
  issn: 1932-6203
  databaseCode: M7S
  dateStart: 20061201
  isFulltext: true
  titleUrlDefault: http://search.proquest.com
  providerName: ProQuest
– providerCode: PRVPQU
  databaseName: Environmental Science Database
  customDbUrl:
  eissn: 1932-6203
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0053866
  issn: 1932-6203
  databaseCode: PATMY
  dateStart: 20061201
  isFulltext: true
  titleUrlDefault: http://search.proquest.com/environmentalscience
  providerName: ProQuest
– providerCode: PRVPQU
  databaseName: Health & Medical Collection
  customDbUrl:
  eissn: 1932-6203
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0053866
  issn: 1932-6203
  databaseCode: 7X7
  dateStart: 20061201
  isFulltext: true
  titleUrlDefault: https://search.proquest.com/healthcomplete
  providerName: ProQuest
– providerCode: PRVPQU
  databaseName: Materials Science Database
  customDbUrl:
  eissn: 1932-6203
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0053866
  issn: 1932-6203
  databaseCode: KB.
  dateStart: 20061201
  isFulltext: true
  titleUrlDefault: http://search.proquest.com/materialsscijournals
  providerName: ProQuest
– providerCode: PRVPQU
  databaseName: Nursing & Allied Health Database
  customDbUrl:
  eissn: 1932-6203
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0053866
  issn: 1932-6203
  databaseCode: 7RV
  dateStart: 20061201
  isFulltext: true
  titleUrlDefault: https://search.proquest.com/nahs
  providerName: ProQuest
– providerCode: PRVPQU
  databaseName: ProQuest Central
  customDbUrl:
  eissn: 1932-6203
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0053866
  issn: 1932-6203
  databaseCode: BENPR
  dateStart: 20061201
  isFulltext: true
  titleUrlDefault: https://www.proquest.com/central
  providerName: ProQuest
– providerCode: PRVPQU
  databaseName: ProQuest Publicly Available Content Database
  customDbUrl:
  eissn: 1932-6203
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0053866
  issn: 1932-6203
  databaseCode: PIMPY
  dateStart: 20061201
  isFulltext: true
  titleUrlDefault: http://search.proquest.com/publiccontent
  providerName: ProQuest
– providerCode: PRVPQU
  databaseName: Public Health Database
  customDbUrl:
  eissn: 1932-6203
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0053866
  issn: 1932-6203
  databaseCode: 8C1
  dateStart: 20061201
  isFulltext: true
  titleUrlDefault: https://search.proquest.com/publichealth
  providerName: ProQuest
– providerCode: PRVATS
  databaseName: Public Library of Science (PLoS) Journals Open Access
  customDbUrl:
  eissn: 1932-6203
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0053866
  issn: 1932-6203
  databaseCode: FPL
  dateStart: 20060101
  isFulltext: true
  titleUrlDefault: http://www.plos.org/publications/
  providerName: Public Library of Science
link http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlR1db9Mw0KIdD7wA40MLjBIQEiCREsdxbIundlq1al2J2lF1vERO4tBKKI2Wdr-fuzQtC2ISvNyDfU7s8519Z9-dCXkXcCa0r7nDNVg6fpZRJ1Y0dnwvFcZXIqOmyjM7EuOxnM9V-NtQ_OMGnwn6uaZpt1jlpltlY1F-ixx4LAjQhWsQjnYrL8huENThcXe1bGw_VZb-_VrcWqArZLv4uSob6mbTWfLW7jN49L_9fkwe1nqm3dsyxiG5Z_In5LCW5NL-UKeb_viUfJkOR7PhJ1vnNj6l5WyP8-1iWWCourFBq7UvHTzgt00B8l8Yu6wez4EZfUa-DU4vT86c-kkFJwm4t3a8lMYi8QUPDCgCSnGZqMSNXUO5VMIYMEspNSmPYdWLpch4ZoRyUzfVScpYzNhz0s5hQEfEllrBzGYJjxPpc5nFTPtoHoIGomA_DCzi7CgdFdvMGVF1fSbA4tgSIULaRDVtLNLH6djjYt7rqgCIGtViFHnKpCbzY8YVWIKSap0yFeiYZSmYZtRY5DVOZrQNIt1Lb9RDs5BJsJ0s8rbCwNwXOTrX_NCbsoyGX2f_gDSdNJDe10jZCjgj0XVAA4wJc2o1MI8bmCDBSfNvCyTGrYGf9UYRlrlMYvpw94Za5Ag5c0e6MvIEqMo-NFfw-R23_r36zb4a_4xedblZbbY4DJ8AYBYRDS5vdKZZky8XVRZy5cNyLsSLu_v1kjzwMFgEr9_EMWmvrzfmFbmf3KyX5XWHtMRkhnAuKigByhPaIQf903E46VSnI51KwAGe97sAL9xzhCKs4BRgyL9Di3B4EV79AvrsTVo
linkProvider Public Library of Science
linkToHtml http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMw1V1bb9MwFLZGQWIvwLhoGYMFBAIkssVxHMdCCJXL1GqlIFamvhkncdZKKAlNO8Sf4jdyTi5lkRDiZQ-8xkdxbH_-fE58LoQ8CjgT2tfc4RosHT9NqRNJGjm-lwjjS5FSU-WZHYnxOJxO5ccN8rONhUG3ypYTK6JO8hj_kR94AjQDH5Rf-ar45mDVKLxdbUto1LA4Mj--g8lWvhy-hfV97HmH7yZvBk5TVcCJA-4tHS-hkYh9wQMDZ6GUPIxl7EauoTyUwhiwzCg1CY9g40ehSHlqhHQTN9FxwliEP0CB8i8Djwt0IRPTtYEH3BEETXgeE_SgQcN-kWdmv8ojI_3O8VdVCVifBZdm6IrZK77mZUfd7Tprnjv9Dq__b_N2g1xr9Gy7X2-MLbJhsptkq2Gy0n7apNt-dou8OB6OTobPbZ3ZWErMqa8z7GJeYKi-sUGrtycOXnDYpgD-K4xdVsWDANG3yecLGcQd0stgObeJHWoJyE5jHsWhz8M0YtpH8xg0MAn6QGARp11pVdSZQ1R1fSjA4qonQSEyVIMMi7xGOKxlMe939SBfnKqGRpQnTWJSP2JcgiUcUq0TJgMdsTQB05Qai-whmFQdRLtmL9VHs5iFAAOLPKwkMPdHhs5Fp3pVlmr44eQfhI4_dYSeNEJpDsiMdRPQAWPCnGIdyd2OJDBY3O1thpNxbuCD_kjhM5eFmD7dPaMW2cad0U5dqX4DG17fQv_PzQ_WzdgzehVmJl_VMgxLIDCLiM4u63xMtyWbz6os7NKH40yInb93vkeuDibvR2o0HB_dJZseBs_gdaTYJb3lYmXukSvx2XJeLu5XVGKTLxe9B38Bg4ewSA
linkToPdf http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMw1V3db9MwELdGQYgXYHxogcECAgESWeM4jmMhhAqjWrWqVGxMEy_GSZy1EkpC0w7xr_HXcZePskgI8bIHXuNT3di_-91d7Lsj5EnAmdC-5g7XEOn4aUqdSNLI8b1EGF-KlJqqzuxYTCbhyYmcbpCfbS4MXqtsObEi6iSP8Rt53xPgGfjg_Mp-2lyLmO4N3xTfHOwghSetbTuNGiIH5sd3CN_K16M92Ounnjd8f_Ru32k6DDhxwL2l4yU0ErEveGDALkrJw1jGbuQaykMpjIEojVKT8AhIIApFylMjpJu4iY4TxiL8GAr0f1lAjImB35R_bq0A8EgQNKl6TNB-g4zdIs_MblVTRvodU1h1DFjbhUszvJbZK77mZcf17V7cPGcJhzf-5zW8Sa43_rc9qBVmk2yY7BbZbBiutJ83Zbhf3CavDkfj49FLW2c2thhz6mMOu5gXmMJvbPD27SMHDz5sUwAvFsYuq6ZCgPQ75NOFvMRd0stga7eIHWoJiE9jHsWhz8M0YtrHsBk8Mwl-QmARp911VdQVRVR1rCggEqsXQSFKVIMSi7xFaKxlsR549SBfnKqGXpQnTWJSP2JcQoQcUq0TJgMdsTSBkJUai-wgsFSdXLtmNTXAcJmFAAmLPK4ksCZIhsg41auyVKMPx_8gdPixI_SsEUpzQGmsm0QPeCesNdaR3O5IArPF3dlmuBjnXnx_MFb4zGUhllV3z6hFtlBL2qUr1W-Qw8-3avDn4UfrYZwZbxtmJl_VMgxbIzCLiI7Gdf5MdySbz6rq7NIHMyfEvb9PvkOuguqp8WhycJ9c8zCnBk8pxTbpLRcr84Bcic-W83LxsGIVm3y5aBX8Baq7uTs
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=SILVI%2C+an+open-source+pipeline+for+T-cell+epitope+selection&rft.jtitle=PloS+one&rft.au=Pissarra%2C+Joana&rft.au=Dorkeld%2C+Franck&rft.au=Loire%2C+Etienne&rft.au=Bonhomme%2C+Vincent&rft.date=2022-09-07&rft.pub=Public+Library+of+Science&rft.issn=1932-6203&rft.eissn=1932-6203&rft.volume=17&rft.issue=9&rft.spage=e0273494&rft_id=info:doi/10.1371%2Fjournal.pone.0273494&rft.externalDBID=ISR&rft.externalDocID=A716438747
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1932-6203&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1932-6203&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1932-6203&client=summon